Pfizer Says 3-Dose COVID-19 Vaccine Is Effective For Children Under 5

Pfizer's three-dose vaccine is reported to be 80% effective against the Omicron variant in children aged six months to five years. Kaiser has released preliminary data and plans to submit it to regulators, pending FDA authorization. The vaccine dosage for this age group is one-tenth of the adult dose.

What age group is the Pfizer vaccine being studied for?

What is the effectiveness of Pfizer's vaccine against the Omicron variant in children aged six months to five years?

What does Kaiser say about the data regarding the vaccine?

What is the planned action by Kaiser regarding the vaccine data?

How does the vaccine dosage for young kids compare to the adult dose?